EXTENDED DOSING INTERVALS AS A DRIVER FOR IMPROVED SUSTAINABILITY Native GLP-1 has a half-life that is measured in mere minutes6 and, as such, has limited therapeutic relevance without continuous dosing
These genetic variations disrupt normal functions that occur in cells, ultimately leading to neurodegeneration (Kovacs, 2016)
Pickart estimated lethal dose at approximately 22,500 mg for humans (300-fold above effective doses), with animal LD50 studies in mice showing 8 mg per 25g mouse (320 mg/kg, translating to ~22,400 mg for 154 lb human)
NAC treatment also reduced, in arterial cord blood, citrulline/arginine ratio ( P 0.03, regardless of IPTB severity) and taurine/cysteine ratio ( P 0.04, mainly in moderate IPTB cases), reflecting NO-synthase activity and oxidative cysteine catabolism, respectively (Fig